0       0

AMDA's 32nd Annual Symposium


A04 - Treatment of Behavior/Complications of Dementia: A Comprehensive Multi-Disciplinary Care Approach


Mar 5, 2009 8:00am ‐ Mar 5, 2009 11:30am

Standard: $24.00

Description

AMDCP Credit Designation:

This session has been approved for a total of 3 Management credit hours toward certification as a Certified Medical Director in Long Term Care (CMD).

The American Medical Directors Association designates this educational activity fora maximum of 3 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Presenter(s): Eric Tangalos, MD, CMD;Ladislav Volicer, MD, PhD; Joyce Simard, MSW; Mara Ferris, RN, GCNS-BC; Leo J.Borrell, MD

Disclosure(s):
LeoJ. Borrell, MD will discuss substances not approvedin the USfor use under discussion - Trazadone AbilifyDepakote Trazadone
Amita Patel, MD received speakerhonoraria from Eli Lilly and Company, Sanofi Aventis,Bros, and WyethPharmaceuticals and a consultant fee from Eli Lilly and Company. Products madeby these companies related to this topic: Cymbalta, Ambien CR, Abilify and Pristiq.
EricTangalos, MD, CMD received a consultant fee from Novartis, a Data MonitoringCommittee fee from Eli Lilly and Company, and an investigator fee from Elan Pharmaceuticals, Inc. Product(s) made by thesecompanies related to this topic: Exelon, Bapineuzumab.
JoyceSimard, MSW received author royalties for a book from Health Profession Press.

Allother presenters reported they had no relevant financial relationships todisclose.

Session Description:
This session makes the case for a comprehensivemulti-disciplinary care approach for treatment of the complex behavioraldisturbances that can occur relative to many situations and conditions ingero-psychiatric patients. For instance, behaviors that are consideredaggressive are very common in patients with Alzheimer's disease occurring inabout 40-90% of patients during the course of their illness. Certain riskfactors include environment, stage of dementia, psychiatric diagnosis,co-morbid medical conditions and psychosocial factors. The challenges of andstrategies for this ideal treatment approach are discussed.

Learning Objectives:
  • Discuss how agitation and resistiveness to care are mistaken asaggression
  • Identify various behavioral approaches such as how continuousactivities for patients with dementia can decrease isolation, psychotropicmedication use and behavioral disturbances
  • Describe barriers related to organizational changes andimplementation of behavior management
  • Explain how to train staff in behavior management using amulti-disciplinary care approach
References:
1. "An Introduction to Belbin Team Roles", byBernard Chanliau
2. Competetive Strategy, Michael Porter.
3. "Effects of Continuous Activities Programming onBehavioral Symptoms of Dementia" L.Volicer at al. J Am Med Dir Assoc,2006: 7: 426-431.
4. Volicer L, Bass EA, Luther SL. Agitation and resistivenessto care are two separate behavioral syndromes of dementia. J Am Med Dir Assoc.8(8):527-32, 2007.
5. Rogers, EverettM. Diffusion of Innovations, (5th ed.). (2003) New York : Free Press. The Anatomy of Buzz:How to Create Word of Mouth Marketing by Emanuel Rosen. The Structure ofScientific Revolutions (1962) publ. Universityof Chicago Press, MichaelKuhns 1962.

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content